Standard Biotools Inc.
LAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001162194
No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding Standard Biotools Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 160 | 1 | 155 | −4 |
| Shares | 280.6M | 36.9K | 285.8M | +5.28M (+1.9%) |
| Value | $336.6M | $44.3K | $371.5M | +$35.0M (+10.4%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Standard Biotools Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JBF Capital, Inc. | 770,654 | $1.00M | 0.14% |
| Abich Financial Wealth Management LLC | 91,448 | $118.9K | 0.04% |
| Virtu Financial LLC | 58,696 | $76.0K | 0.00% |
| Boothbay Fund Management, LLC | 36,714 | $47.7K | 0.00% |
| CIBC Bancorp USA Inc. | 31,908 | $41.5K | 0.00% |
| GTS Securities LLC | 20,538 | $26.7K | 0.00% |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 10,454 | $13.6K | 0.00% |
| Advisory Services Network, LLC | 6,490 | $8.44K | 0.00% |
| Optiver Holding B.V. | 3,864 | $5.02K | 0.00% |
| SRS Capital Advisors, Inc. | 2,749 | $3.57K | 0.00% |
| Fortitude Family Office, LLC | 793 | $1.03K | 0.00% |
| Wealthspire Advisors, LLC | 200 | $260 | 0.00% |
| Sunbelt Securities, Inc. | 179 | $233 | 0.00% |
Sold out (17)
Institutions that held Standard Biotools Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Mirabella Financial Services LLP | 3,434,387 | $4.12M |
| Kent Lake PR LLC | 1,000,000 | $1.20M |
| Gsa Capital Partners LLP | 306,487 | $368.0K |
| Quadrature Capital Ltd | 84,162 | $100.6K |
| Wexford Capital LP | 83,638 | $100.4K |
| Point72 Asia (Singapore) Pte. Ltd. | 71,690 | $86.0K |
| Squarepoint Ops LLC | 43,253 | $51.9K |
| Paradigm Capital Management Inc | 17,457 | $20.9K |
| Two Sigma Securities, LLC | 15,599 | $18.7K |
| R Squared Ltd | 12,947 | $15.5K |
| Callan Family Office, LLC | 11,875 | $14.3K |
| Apollon Wealth Management, LLC | 11,543 | $13.9K |
| Point72 (DIFC) Ltd | 10,992 | $13.2K |
| Cubist Systematic Strategies, LLC | 6,551 | $7.86K |
| Raymond James Financial Inc | 3,881 | $4.66K |
| Bellwether Advisors, LLC | 2,016 | $2.42K |
| Caitong International Asset Management Co., Ltd | 1,932 | $2.32K |
Not filed for Q3 2025 yet (1)
Institutions that held Standard Biotools Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| CIBC World Markets Corp | 36,882 | $44.3K |